Integral Molecular and Optimeos Partner to Deliver Long-acting Therapeutic Antibodies Using Nanoparticle Formulation Technology1/7/21
Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin11/24/20